Travere Therapeutics, Inc (TVTX) insider trading
Every open-market stock purchase and sale by Travere Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Eric M Dube (CEO) and 8 others sold $80.1M in the last 90 days.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $117M (62 sales). Last close $52.43 on Oct 22, 2026.
Recent TVTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 15, 2026 | Eric M Dube (CEO) | Sold | $6.8M |
| Oct 15, 2026 | Eric M Dube (CEO) | Sold | $4.3M |
| Oct 15, 2026 | Eric M Dube (CEO) | Sold | $2M |
| Oct 15, 2026 | Eric M Dube (CEO) | Bought (not open market) | $1.8M |
| Oct 15, 2026 | Eric M Dube (CEO) | Bought (not open market) | $1.2M |
| Oct 15, 2026 | Eric M Dube (CEO) | Bought (not open market) | — |
| Oct 15, 2026 | Eric M Dube (CEO) | Bought (not open market) | — |
| Sep 17, 2026 | Eric M Dube (CEO) | Sold | $6.6M |
| Sep 17, 2026 | Peter Heerma (C-suite exec) | Sold | $539K |
| Sep 17, 2026 | Eric M Dube (CEO) | Sold | $442K |
| Sep 17, 2026 | Peter Heerma (C-suite exec) | Bought (not open market) | — |
| Sep 17, 2026 | Eric M Dube (CEO) | Bought (not open market) | — |
| Sep 16, 2026 | Eric M Dube (CEO) | Sold | $6.3M |
| Sep 16, 2026 | Eric M Dube (CEO) | Sold | $6.1M |
| Sep 16, 2026 | Peter Heerma (C-suite exec) | Sold | $5.9M |
| Sep 16, 2026 | Peter Heerma (C-suite exec) | Sold | $5M |
| Sep 16, 2026 | William E. Rote (C-suite exec) | Sold | $4.1M |
| Sep 16, 2026 | William E. Rote (C-suite exec) | Sold | $3M |
| Sep 16, 2026 | Eric M Dube (CEO) | Bought (not open market) | — |
| Sep 16, 2026 | William E. Rote (C-suite exec) | Bought (not open market) | — |
| Sep 16, 2026 | William E. Rote (C-suite exec) | Bought (not open market) | — |
| Sep 16, 2026 | Peter Heerma (C-suite exec) | Bought (not open market) | — |
| Sep 16, 2026 | William E. Rote (C-suite exec) | Bought (not open market) | — |
| Sep 16, 2026 | Peter Heerma (C-suite exec) | Bought (not open market) | — |
| Sep 16, 2026 | Peter Heerma (C-suite exec) | Bought (not open market) | — |
Who's trading TVTX
- Eric M Dube, CEO: sold $54.5M (24 sales), last Oct 15, 2026
- Peter Heerma, C-suite exec: sold $19M (13 sales), last Sep 17, 2026
- William E. Rote, C-suite exec: sold $16.4M (10 sales), last Sep 16, 2026
- Christopher R. Cline, CFO: sold $4.6M (15 sales), last Sep 15, 2026
- Jula Inrig, C-suite exec: sold $5.2M (15 sales), last Sep 15, 2026
- Elizabeth E Reed, C-suite exec: sold $7M (19 sales), last Sep 15, 2026
- Sandra Calvin, C-suite exec: sold $4.2M (8 sales), last Sep 15, 2026
- Jeffrey A Meckler, Insider: sold $1.7M (5 sales), last Sep 10, 2026
- Gary A Lyons, Insider: sold $961K (6 sales), last Aug 18, 2026
- Roy D. Baynes, Insider: sold $2.5M (6 sales), last Jun 12, 2026
- Timothy Coughlin, Insider: sold $1.3M (3 sales), last Jun 12, 2026
- John A Orwin, Insider: other filings, last May 19, 2026
- Sandra Poole, Insider: other filings, last May 19, 2026
- Suzanne Louise Bruhn, Insider: other filings, last May 19, 2026
- Ron Squarer, Insider: other filings, last May 19, 2026
Get free alerts when an insider at Travere Therapeutics, Inc files a new trade →